Re: Employment AgreementEmployment Agreement • March 4th, 2010 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • Colorado
Contract Type FiledMarch 4th, 2010 Company Industry JurisdictionARCA biopharma, Inc. (the “Company”) is pleased to offer you the following agreement regarding your employment as the Company’s Senior Vice President, Finance and certain severance benefits (the “Agreement”). This Agreement amends, supersedes and terminates any and all prior agreements or understandings with respect to your employment terms and severance benefits; provided, however, that, except as otherwise expressly provided, the Employee Intellectual Property Agreement (as defined below) is not modified or terminated hereby, and shall continue in full force and effect.
Re: Amended and Restated Employment and Retention AgreementEmployment Agreement • March 27th, 2009 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • Colorado
Contract Type FiledMarch 27th, 2009 Company Industry JurisdictionARCA biopharma, Inc. (the “Company”) is pleased to offer you the following agreement regarding your employment as the Company’s Executive Vice President Business Development and General Counsel and certain severance benefits (the “Agreement”). This Agreement amends, supersedes and terminates any and all prior agreements with respect to your employment terms and severance benefits, including but not limited to, that certain Offer Letter and Letter Agreement dated January 1, 2005; provided, however, that, except as otherwise expressly provided, the Employee Intellectual Property Agreement (as defined below) is not modified or terminated hereby, and shall continue in full force and effect.
Re: Employment AgreementEmployment Agreement • March 27th, 2009 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • Colorado
Contract Type FiledMarch 27th, 2009 Company Industry JurisdictionARCA biopharma, Inc. (the “Company”) is pleased to offer you the following agreement regarding your employment as the Company’s Executive Vice President of Commercial Operations and certain severance benefits (the “Agreement”). This Agreement amends, supersedes and terminates any and all prior agreements or understandings with respect to your employment terms and severance benefits; provided, however, that, except as otherwise expressly provided, the Employee Intellectual Property Agreement (as defined below) is not modified or terminated hereby, and shall continue in full force and effect.
Re: Amended and Restated Employment and Retention AgreementEmployment Agreement • March 27th, 2009 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • Colorado
Contract Type FiledMarch 27th, 2009 Company Industry JurisdictionARCA biopharma, Inc. (the “Company”) is pleased to offer you the following agreement regarding your employment as the Company’s Chairman and Chief Science and Medical Officer and certain severance benefits (the “Agreement”). This Agreement amends, supersedes and terminates any and all prior agreements with respect to your employment terms and severance benefits, including but not limited to, that certain Offer Letter and Letter Agreement dated January 1, 2005; provided, however, that, except as otherwise expressly provided, the Employee Intellectual Property Agreement (as defined below) is not modified or terminated hereby, and shall continue in full force and effect.
Re: Employment AgreementEmployment Agreement • March 27th, 2009 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • Colorado
Contract Type FiledMarch 27th, 2009 Company Industry JurisdictionARCA biopharma, Inc. (the “Company”) is pleased to offer you the following agreement regarding your employment as the Company’s Chief Financial Officer and Chief Operating Officer and certain severance benefits (the “Agreement”). This Agreement amends, supersedes and terminates any and all prior agreements or understandings with respect to your employment terms and severance benefits, including but not limited to, that certain Offer Letter dated February 18, 2009; provided, however, that, except as otherwise expressly provided, the Employee Intellectual Property Agreement (as defined below) is not modified or terminated hereby, and shall continue in full force and effect.